HALO

NASD Halozyme Therapeutics, Inc.
Oct 8, 2026 · 8:57 AM ET LAST TRADE Market Closed

$110.02 ↓ -0.77 (-0.70%) Trading Down from the previous close of $110.79

YTD change
+63.47%
vs 20-day SMA
-0.33%
vs 200-day SMA
+39.27%

Price ranges

Previous day
$110.16 $114.00
open $111.62 close $110.79
-$0.83 (-0.74%)
Today
$0.00 $0.00
$110.02
Past week
$106.65 $114.00
from $110.40 now $110.02
-$0.38 (-0.35%)
Past month
$105.50 $116.85
from $107.39 now $110.02
+$2.63 (+2.45%)
This year
$61.33 $116.85
from $67.30 now $110.02
+$42.72 (+63.47%)

Price & Performance

+45.36 (+69.33%) / 6M

$58.89$79.06$99.22$119.39Apr 8Jul 9Oct 7

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 5.8% away from all-time highs of $116.85
  • HALO is up 63% since the beginning of the year
  • HALO is up 69% over the past 12 months
  • HALO is up 2% over the past 1 month
  • 13% of all HALO investors are betting against HALO

HALO reads neutral: price sits above one of the two key moving averages, the 12-month move is +69.9%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $2.28
Earnings momentum -0.0% Quarterly EPS growth
Quarterly change -0.0%

Valuation

P/E ratio 31.99
Enterprise value $15.3B
Beta 0.56

Balance sheet & scale

Income$413.6K
Revenue$1.7B
Cash$231.0M
Debt$2.1M
Income / Debt 0.19×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $12.5B

Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,188.72 +2.70%
JNJ Johnson & Johnson $258.45 +1.44%
ABBV AbbVie, Inc. $271.36 +1.75%
MRK Merck & Co., Inc. $142.79 +0.60%
RHHBY Roche Holding Ltd Sponsored ADR $54.07 +2.89%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.